{
    "organizations": [],
    "uuid": "495e9108789dbc8574204b01a90c7111b8ab1f5d",
    "author": "",
    "url": "https://www.reuters.com/article/brief-humco-and-fagron-to-combine-for-up/brief-humco-and-fagron-to-combine-for-up-to-70-million-dollars-idUSFWN1RG0QR",
    "ord_in_thread": 0,
    "title": "BRIEF-Humco And Fagron To Combine For Up To 70 Million Dollars",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 3, 2018 / 4:06 PM / in 26 minutes BRIEF-Humco And Fagron To Combine For Up To 70 Million Dollars Reuters Staff \nApril 3 (Reuters) - FAGRON NV: * HUMCO AND FAGRON TO COMBINE FOR UP TO US $70 MILLION \n* ‍GREGORY PULIDO, HUMCO’S CHAIRMAN AND CHIEF EXECUTIVE OFFICER, WILL TRANSITION TO ROLE OF EXECUTIVE CHAIRMAN​ \n* ANDREW PULIDO, HUMCO’S CURRENT PRESIDENT, GLOBAL PHARMACEUTICALS, WILL ASSUME THE SOLE ROLE OF PRESIDENT AT HUMCO Source text for Eikon: Further company coverage: (Gdynia Newsroom)",
    "published": "2018-04-03T19:06:00.000+03:00",
    "crawled": "2018-04-03T19:34:40.011+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "pm",
        "minute",
        "fagron",
        "combine",
        "million",
        "dollar",
        "reuters",
        "staff",
        "april",
        "reuters",
        "fagron",
        "nv",
        "humco",
        "fagron",
        "combine",
        "u",
        "million",
        "pulido",
        "humco",
        "chairman",
        "chief",
        "executive",
        "officer",
        "transition",
        "role",
        "executive",
        "andrew",
        "pulido",
        "humco",
        "current",
        "president",
        "global",
        "pharmaceutical",
        "assume",
        "sole",
        "role",
        "president",
        "humco",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "gdynia",
        "newsroom"
    ]
}